Detalhe da pesquisa
1.
Food and Drug Administration Public Workshop Summary-Development Considerations of Antifungal Drugs to Address Unmet Medical Need.
Clin Infect Dis
; 77(3): 380-387, 2023 08 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37021650
2.
Systemic antifungal therapy with isavuconazonium sulfate or other agents in adults with invasive mucormycosis or invasive aspergillosis (non-fumigatus): A multicentre, non-interventional registry study.
Mycoses
; 65(2): 186-198, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34888961
3.
Efficacy and Associated Drug Exposures of Isavuconazole and Fluconazole in an Experimental Model of Coccidioidomycosis.
Antimicrob Agents Chemother
; 65(6)2021 05 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-33782009
4.
Safety, Tolerability, and Population Pharmacokinetics of Intravenous and Oral Isavuconazonium Sulfate in Pediatric Patients.
Antimicrob Agents Chemother
; 65(8): e0029021, 2021 07 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-34031051
5.
Antifungal efficacy of isavuconazole and liposomal amphotericin B in a rabbit model of Exserohilum rostratum meningoencephalitis: A preclinical paradigm for management of CNS phaeohyphomycosis.
Med Mycol
; 59(2): 189-196, 2021 Feb 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33313821
6.
Isavuconazole Versus Caspofungin in the Treatment of Candidemia and Other Invasive Candida Infections: The ACTIVE Trial.
Clin Infect Dis
; 68(12): 1981-1989, 2019 05 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-30289478
7.
Population Pharmacokinetic Modeling of VL-2397, a Novel Systemic Antifungal Agent: Analysis of a Single- and Multiple-Ascending-Dose Study in Healthy Subjects.
Antimicrob Agents Chemother
; 63(6)2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30988142
8.
Outcomes by MIC Values for Patients Treated with Isavuconazole or Voriconazole for Invasive Aspergillosis in the Phase 3 SECURE and VITAL Trials.
Antimicrob Agents Chemother
; 63(1)2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30373791
9.
Pharmacodynamics of Isavuconazole in a Rabbit Model of Cryptococcal Meningoencephalitis.
Antimicrob Agents Chemother
; 63(9)2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31209006
10.
Isavuconazole Concentration in Real-World Practice: Consistency with Results from Clinical Trials.
Antimicrob Agents Chemother
; 62(7)2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29735569
11.
In Vitro Activity of Isavuconazole against Opportunistic Fungal Pathogens from Two Mycology Reference Laboratories.
Antimicrob Agents Chemother
; 62(10)2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30061288
12.
Treatment outcomes in patients with proven/probable vs possible invasive mould disease in a phase III trial comparing isavuconazole vs voriconazole.
Mycoses
; 61(11): 868-876, 2018 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-30035825
13.
Pharmacodynamics of Isavuconazole for Invasive Mold Disease: Role of Galactomannan for Real-Time Monitoring of Therapeutic Response.
Clin Infect Dis
; 64(11): 1557-1563, 2017 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28472247
14.
Prophylaxis with Isavuconazole or Posaconazole Protects Immunosuppressed Mice from Pulmonary Mucormycosis.
Antimicrob Agents Chemother
; 61(5)2017 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28264840
15.
Impact of Mucositis on Absorption and Systemic Drug Exposure of Isavuconazole.
Antimicrob Agents Chemother
; 61(6)2017 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28289034
16.
The Emerging Pathogen Candida auris: Growth Phenotype, Virulence Factors, Activity of Antifungals, and Effect of SCY-078, a Novel Glucan Synthesis Inhibitor, on Growth Morphology and Biofilm Formation.
Antimicrob Agents Chemother
; 61(5)2017 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28223375
17.
Exposure-Response Relationships for Isavuconazole in Patients with Invasive Aspergillosis and Other Filamentous Fungi.
Antimicrob Agents Chemother
; 61(12)2017 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-28923872
18.
Combination Therapy with Isavuconazole and Micafungin for Treatment of Experimental Invasive Pulmonary Aspergillosis.
Antimicrob Agents Chemother
; 61(9)2017 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28696236
19.
In vitro combination therapy with isavuconazole against Candida spp.
Med Mycol
; 55(8): 859-868, 2017 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28204571
20.
Prognostic value of galactomannan: current evidence for monitoring response to antifungal therapy in patients with invasive aspergillosis.
J Pharmacokinet Pharmacodyn
; 44(2): 143-151, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28181136